2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow bezlotoxumab: new trials by email Literature Review of bezlotoxumab trials Research Report on bezlotoxumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection Bezlotoxumab, Normal saline 0.9% or 5% dextrose water - Clostridioides Difficile Infection, Stool Microbiome | Phase 2 | Completed | Hellenic Institute for the Study of Sepsis | 44 | 2022-04-13 | 2026-03-04 |
| ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI Bezlotoxumab, Placebo, Fecal Microbiota Transplantation - Inflammatory Bowel Diseases, Clostridium Difficile Infection | Phase 2 | Completed | Brigham and Women's Hospital | 61 | 2020-01-01 | 2025-12-09 |
Clostridium Infections (2) · Colitis, Ulcerative (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1)
Brigham and Women's Hospital (1) · Hellenic Institute for the Study of Sepsis (1)
Greece (1) · United States (1)
Evangelos J Giamarellos-Bourboulis, MD, PhD (1)